Michelle E. Ramey

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens

Nicholas D. Walter, Sarah E. M. Born, Gregory T. Robertson et al. · Nature Communications · 2021 · 88 citations · Full text

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832

Gregory T. Robertson, Michelle E. Ramey, Lisa M. Massoudi et al. · Antimicrobial Agents and Chemotherapy · 2021 · 76 citations · Full text

Tuberculosis Treatment, Drug Target, Dpre1 Inhibitors Tba-7371 +19

Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responses

Nicholas D. Walter, Jacqueline P. Ernest, Christian Dide-Agossou et al. · Antimicrobial Agents and Chemotherapy · 2023 · 28 citations · Full text

Digital Image Analysis of Heterogeneous Tuberculosis Pulmonary Pathology in Non-Clinical Animal Models using Deep Convolutional Neural Networks

Bryce Asay, Blake Blue Edwards, Jenna Andrews et al. · Scientific Reports · 2020 · 25 citations · Full text

Convolutional Neural Network, Engineering, Digital Pathology +25

Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments

Christian Dide-Agossou, Allison Bauman, Michelle E. Ramey et al. · Antimicrobial Agents and Chemotherapy · 2022 · 23 citations · Full text

Immunology, Pharmacotherapy, Antimicrobial Chemotherapy +19